iCoreConnect (ICCT) Stock Price, News & Analysis

Company Overview

iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.

Key Stats

• Today's Range: $0.17 to $0.18
• 50-Day Range: $0.16 to $0.60
• 52-Week Range: $0.15 to $3.20
• Volume: 1.92 million shs
• Average Volume: 1.29 million shs
• Market Capitalization: $2.09 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

iCoreConnect Stock Analysis - MarketRank™

iCoreConnect scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for iCoreConnect.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of iCoreConnect is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of iCoreConnect is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

iCoreConnect has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.70% of the float of iCoreConnect has been sold short.

Short Interest Ratio / Days to Cover

iCoreConnect has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iCoreConnect has recently decreased by 24.73%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iCoreConnect does not currently pay a dividend.

Dividend Growth

iCoreConnect does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.70% of the float of iCoreConnect has been sold short.

Short Interest Ratio / Days to Cover

iCoreConnect has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iCoreConnect has recently decreased by 24.73%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.50

News Sentiment

iCoreConnect has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for iCoreConnect this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for ICCT on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

1 people have added iCoreConnect to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iCoreConnect insiders have not sold or bought any company stock.

Percentage Held by Insiders

59.42% of the stock of iCoreConnect is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 13.42% of the stock of iCoreConnect is held by institutions.

ICCT Stock Analysis - Frequently Asked Questions

How have ICCT shares performed this year?

iCoreConnect's stock was trading at $1.24 at the beginning of 2024. Since then, ICCT stock has decreased by 86.2% and is now trading at $0.1711.
View the best growth stocks for 2024 here.

How do I buy shares of iCoreConnect?

Shares of ICCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of iCoreConnect own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iCoreConnect investors own include Tilray (TLRY), Recursion Pharmaceuticals (RXRX), Editas Medicine (EDIT), Pacific Biosciences of California (PACB), Akanda (AKAN), SoundHound AI (SOUN) and Aridis Pharmaceuticals (ARDS).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:ICCT
• CUSIP: N/A
• CIK: 1906133
• Web: www.icoreconnect.com
• Phone: 888-810-7706
• Fax: N/A
• Employees: 67
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-15,550,000.00
• Net Margins: -260.79%
• Pretax Margin: -260.27%
• Return on Equity: -614.22%
• Return on Assets: -152.86%

Debt

• Debt-to-Equity Ratio: 7.93
• Current Ratio: 0.11
• Quick Ratio: 0.11

Sales & Book Value

• Annual Sales: $10.27 million
• Price / Sales: 0.20
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.50 per share
• Price / Book: 0.34

Miscellaneous

• Outstanding Shares: 11,983,000
• Free Float: 4,863,000
• Market Cap: $2.05 million
• Optionable: Not Optionable
• Beta: 0.69